- In July 2024, Agilent Technologies has announced the acquisition of Canadian drug services firm BioVectra for USD 925 million. This move expands Agilent's capabilities in gene editing, specifically in manufacturing oligonucleotides and peptides, enhancing its role in RNA-based therapies and gene editing technologies like CRISPR-Cas
- In June 2024, Thermo Fisher celebrated the ribbon-cutting of a 72,500-square-foot expansion at its Middleton campus, which will serve as a laboratory for pharmaceutical testing. The project will create 350 jobs over the next two years, with state tax credits supporting the initiative
- In November 2024, Sartorius Stedim Biotech has opened a new Center for Bioprocess Innovation in Marlborough, Massachusetts, aimed at advancing the development of next-generation therapeutics. The 63,000-square-foot facility will provide process optimization, training, and GMP suites for clinical production starting in 2025
- In March 2024, Beckman Coulter Life Sciences has launched the CytoFLEX nano Flow Cytometer, a breakthrough in nanoparticle analysis that enables detection as small as 40 nm. This system enhances sensitivity, offering up to 50% more data for research into extracellular vesicles and lower-abundance targets
- In March 2024, Beckman Coulter Life Sciences has received FDA 510(k) clearance to distribute its DxFLEX Clinical Flow Cytometer in the U.S. This simplifies high-complexity testing with enhanced sensitivity and automated compensation, making multicolor flow cytometry more accessible and efficient for labs
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services, and Software), Technology (Cell-Based Flow Cytometry and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Pharmaceuticals and Biotechnology Companies, Academic & Research Institutes, Hospitals, Clinical Testing Laboratories, CRO, Blood Bank, CMO & CDMO, Forensic Laboratories, and Others), Distribution Channel (Retail Sales and Direct Tenders) - Industry Trends & Forecast to 2032
.
The North America Flow Cytometry Market size was valued at USD 3.40 USD Billion in 2024.
The North America Flow Cytometry Market is projected to grow at a CAGR of 10.8% during the forecast period of 2025 to 2032.
The major players operating in the market include Thermo Fisher Scientific Inc. , BD AGilent TechnologiesInc. , Nexcelom Bioscience LLC , Bio-Rad LaboratoriesInc. , Sysmex Corporation, Miltenyi Biotec Coherent Corp. , Beckman CoulterInc. , Cytek Biosciences , BIOMÉ,RIEUX , Q2 Solutions , Cytonome/STLLC , Merck KGaA , Sony Biotechnology Inc. , Cell Signaling TechnologyInc. , NanoCellect Biomedical , Apogee Flow Systems Ltd. , Bay bioscience Co.Ltd. , StratedigmInc., BioLegendInc. , NeoGenomics Laboratories, Enzo Biochem Inc. , Union BiometricaInc. , BennuBio Inc. , ORLFO Technologies, Elabscience Biotechnology Inc. , Takara Bio Inc. , .
